Stockreport

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea [Yahoo! Finance Canada]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Tirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with reducin [Read more]